Scientists from the UK and Canada have identified drug compounds to cure a fatal parasitic disease found in sub-Saharan Africa commonly known as sleeping sickness.
Also known as human African trypanosomiasis (HAT), the disease disrupts the sleep cycle when parasites infect the brain.
Some 30 years ago the drug Eflornithine was introduced for treatment of the disease, which is spread through tsetse flies.
